Figure 1 | Scientific Reports

Figure 1

From: Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment

Figure 1The alternative text for this image may have been generated using AI.

Serum neurofilament light chain (sNfL) levels in relapsing–remitting multiple sclerosis (RRMS) patients. sNfL concentration (median, IQR) obtained in 80 RRMS patients at baseline (Basal) and 3, 6, and 12 months (M) after dimethyl fumarate initiation. ****p < 0.0001; ns not significant.

Back to article page